GlassScriptPhysician profile
Fathi I Ali
NPI 1811905409
$7,763.37
in general payments reported to CMS, 2019-2025
34 companies · $935 in 2025
The $935 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $700 · 2020: $216 · 2021: $1,092 · 2022: $2,453 · 2023: $1,229 · 2024: $1,138 · 2025: $935.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,301.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,301.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,519.56 | 2022-2024 | Micra |
| Novartis Pharmaceuticals Corporation | $947.10 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $687.84 | 2019-2025 | Eliquis, Camzyos |
| Amgen INC. | $630.28 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $452.18 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $444.12 | 2019-2025 | Lifevest |
| Abbott Laboratories | $360.12 | 2019-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit, Supera |
| Janssen Pharmaceuticals, INC | $347.65 | 2020-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $331.98 | 2019-2025 | Farxiga, Brilinta |
| Merck Sharp & Dohme LLC | $300.57 | 2021-2025 | Verquvo |
| Boston Scientific Corporation | $215.39 | 2022-2025 | Cds - Mct/Cem Monitoring, Bodyguardian, Watchman Access System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $198.63 | 2023-2025 | Jardiance |
| Sanofi-Aventis U.S. LLC | $185.67 | 2019-2023 | |
| Abiomed | $169.48 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $160.40 | 2021-2023 | Opsumit, Uptravi |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $118.92 | 2024 | Zio Xt Patch, Zio Monitor |
| Novo Nordisk INC | $110.50 | 2023-2025 | Ozempic, Wegovy, Rybelsus |
| Baxter Healthcare | $91.86 | 2023-2025 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Kiniksa Pharmaceuticals, LTD. | $89.88 | 2023 | Arcalyst |
| Esperion Therapeutics, INC. | $53.53 | 2020-2021 | |
| Kiniksa Pharmaceuticals International, Plc | $41.10 | 2024 | Arcalyst |
| Glaxosmithkline, LLC. | $35.72 | 2025 | Arexvy, Shingrix |
| Bayer Healthcare Pharmaceuticals INC. | $35.34 | 2025 | |
| Cvrx, INC. | $32.40 | 2024 | Barostim Neo System |
| Lundbeck LLC | $32.04 | 2019 | |
| Amarin Pharma, INC. | $26.49 | 2020 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $23.28 | 2025 | Caplyta |
| Alnylam Pharmaceuticals INC. | $22.29 | 2024 | Onpattro |
| Shockwave Medical, INC | $21.42 | 2024 | Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Recor Medical INC | $18.75 | 2024 | Paradise Renal Denervation System |
| Zoll Circulation INC | $18.24 | 2023 | Therox Ds2 Console, Catheter, Downstream Cartridge |
| Celonova Biosciences, INC. | $14.22 | 2019 | |
| Vital Connect, INC | $13.66 | 2023 | Vitalpatch Rtm |
| Chiesi USA, INC. | $12.76 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fathi Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.